Last Update Time: 07-Mar-2025 16:00:00
ISIN: INE474Q01031
Sector: Healthcare
Symbol: MEDANTA

Global Health Limited

₹1,225.00 ₹-27.95 (-2.23%) ▼
Prev. Close ₹1,252.95
Open ₹1,243.10
Close ₹1,226.20
Range ₹1,163.75 - ₹1,286.25
High ₹1,260.20
Low ₹1,219.05
Ind. Close ₹0.00
VWAP ₹1,235.42

The current stock price of Global Health Limited is ₹1,225.00, with a target price range between ₹1,163.75 and ₹1,286.25. The stock has experienced a price change of ₹-27.95 (-2.23%), reflecting recent market volatility.

Today's opening price was ₹1,243.10, while the previous close stood at ₹1,252.95.

The market trend suggests a potential downtrend, with investors exercising caution due to recent declines. Analysts recommend closely monitoring support levels.

For real-time stock market updates, live share prices, and stock analysis, stay tuned. Understanding key stock metrics like VWAP, high-low range, and market momentum can help traders make informed investment decisions.

Global Health Limited Price Chart

Global Health Limited Pre Open Market Overview: 07-Mar-2025

Key Metrics:

  • IEP (Indicative Equilibrium Price): 1243.1
  • Previous Close Price: 1252.95
  • Change: -9.85%
  • Total Traded Volume: 1,387
  • Total Buy Quantity: 4,656
  • Total Sell Quantity: 14,834
PriceBuy QtySell Qty
1,239.0010.000.00
1,240.00115.000.00
1,241.501.000.00
1,243.0550.000.00
1,243.1070.000.00
1,243.800.001.00
1,244.000.004.00
1,244.700.00100.00
1,247.250.0014.00
1,248.950.0016.00

ATO Data:

  • Buy Quantity (ATO): 0
  • Sell Quantity (ATO): 0

Order Book

BidQtyAskQty
0.0000.000
0.0000.000
0.0000.000
0.0000.000
0.0000.000
Total Buy Quantity: 4656 Total Sell Quantity: 14834

Shareholding Patterns of Global Health Limited

Key Trade Statistics of Global Health Limited

Trade InformationDetails
Traded Volume (Lakhs)3.09
Traded Value (₹ Cr.)38.16
Total Market Cap (₹ Cr.)32,901.95
Free Float Market Cap (₹ Cr.)10,154.07
Impact cost0.06
Quantity Traded308,865.00
Deliverable Quantity161,156.00
% of Quantity to Traded52.18
Security VaR14.16
Index VaRN/A
VaR Margin14.16
Extreme Loss Rate3.5
Adhoc MarginN/A
Applicable Margin Rate17.66
Face Value2

Key Price Statistics of Global Health Limited

The 52-week high for Global Health Limited was ₹1,511.00, recorded on 30-Apr-2024. On the other hand, the 52-week low stands at ₹935.50, with the lowest value recorded on 07-Oct-2024.

The upper band for trading is ₹1,503.50, and the lower band is ₹1,002.40. The price band is 20%.

The stock's daily volatility stands at 2.21, while the annualized volatility is 42.22. The tick size for trading is ₹0.05.

Price InformationDetails
52 Week High (30-Apr-2024)1,511.00
52 Week Low (07-Oct-2024)935.50
Upper Band1,503.50
Lower Band1,002.40
Price Band (%)20
Daily Volatility2.21
Annualised Volatility42.22
Tick Size0.05

Key Securities Statistics of Global Health Limited

Securities InformationDetails
StatusListed
Trading StatusActive
Date of Listing16-Nov-2022
Adjusted P/E66.34
Symbol P/E66.34
IndexNIFTY 500
Macro-Economic SectorHealthcare
SectorHealthcare
IndustryHealthcare Services
Basic IndustryHospital

Security Status of Global Health Limited

TitleDetails
Board StatusMain
Trading SegmentNormal Market
Session No.-
Class of SharesEquity
SDD Compliance-
Name of Compliance Officer-

Announcements of Global Health Limited

SubjectDate
Analysts/Institutional Investor Meet/Con. Call Updates 04-Mar-2025
Analysts/Institutional Investor Meet/Con. Call Updates 01-Mar-2025
Analysts/Institutional Investor Meet/Con. Call Updates 01-Mar-2025
Amalgamation/Merger 01-Mar-2025
Analysts/Institutional Investor Meet/Con. Call Updates 21-Feb-2025
Amalgamation/Merger 21-Feb-2025
Amalgamation/Merger 20-Feb-2025
Integrated Filing- Financial 17-Feb-2025

Corporate Actions of Global Health Limited

Face ValuePurposeEx-DateStart DateEnd Date
No corporate actions available

Board Meetings of Global Health Limited

PurposeDetailsAtt.Mtg. Date
Board Meeting IntimationGLOBAL HEALTH LIMITED has informed the Exchange about Board Meeting to be held on 04-Feb-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2024 . 04-Feb-2025
Financial ResultsTo consider and approve the financial results for the period ended December 31, 2024 04-Feb-2025
Board Meeting IntimationGLOBAL HEALTH LIMITED has informed the Exchange about Board Meeting to be held on 14-Nov-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2024 . 14-Nov-2024
Financial ResultsTo consider and approve the financial results for the period ended September 30, 2024 14-Nov-2024
GLOBAL HEALTH LIMITED has informed the Exchange about Board Meeting to be held on 08-Aug-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2024 .Board Meeting Intimation 08-Aug-2024
Financial ResultsTo consider and approve the financial results for the period ended Jun 30, 2024 08-Aug-2024
GLOBAL HEALTH LIMITED has informed the Exchange about Board Meeting to be held on 17-May-2024 to inter-alia consider and approve the Audited Financial results of the Company for the Yearly ended March 2024 .Board Meeting Intimation 17-May-2024
Financial ResultsTo consider and approve the Standalone and Consolidated Audited Financial Results of the Company for the Fourth Quarter and Financial Year ended March 31, 2024. 17-May-2024
GLOBAL HEALTH LIMITED has informed the Exchange about Board Meeting to be held on 08-Feb-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2023 .Board Meeting Intimation 08-Feb-2024
Financial ResultsTo consider and approve the financial results for the period ended December 31, 2023 08-Feb-2024
GLOBAL HEALTH LIMITED has informed the Exchange about Board Meeting to be held on 09-Nov-2023 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2023 .Board Meeting Intimation 09-Nov-2023
Financial ResultsTo consider and approve the financial results for the period ended September 30, 2023 09-Nov-2023
Financial ResultsTo consider and approve the financial results for the period ended Jun 30, 2023 10-Aug-2023
GLOBAL HEALTH LIMITED has informed the Exchange about Board Meeting to be held on 10-Aug-2023 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2023 .Board Meeting Intimation 10-Aug-2023
GLOBAL HEALTH LIMITED has informed the Exchange about Board Meeting to be held on 27-May-2023 to inter-alia consider and approve the Audited Financial results of the Company for the Yearly ended March 2023 .Board Meeting Intimation 27-May-2023
Financial ResultsTo consider and approve the financial results for the period ended March 31, 2023 27-May-2023
Financial ResultsTo consider and approve the financial results for the period ended December 31, 2022 13-Feb-2023

Financial Results of Global Health Limited

Company Directory of Global Health Limited

Web AddressSM NameOfficeAddressCityPincodeTelephoneEmail
N/AGlobal Health LimitedHead Office/ Corporate OfficeMedanta The Medicity
sector 38
gurgaon
GURGAON122001124-483 4060compliance@medanta.org
N/AGlobal Health LimitedRegistered OfficeE-18
DEFENCE COLONY
NEW DELHI
DELHI110024011-44114411compliance@medanta.org
N/AGlobal Health LimitedTransfer AgentSelenium, Tower-B Plot 31 and 32
Financial District Nanakramguda, Serilingampally
Hyderabad
Rangareddi
MUMBAI500032+91 40-6716 2222globalhealth.ipo@kfintech.com

Insider Trading of Global Health Limited

Reg. ClauseAcq./Disp.Sec. (No.)Sec. ValueTxn TypeBcast Time
No insider trading information available

Annual Reports of Global Health Limited

CompanyFrom YearTo YearAtt.
Global Health Limited20232024
Global Health Limited20222023

Investor Complaints of Global Health Limited

Event Calendar of Global Health Limited

CompanyPurposeDetailsDate
Global Health LimitedFinancial ResultsTo consider and approve the financial results for the period ended December 31, 202213-Feb-2023
Global Health LimitedFinancial ResultsTo consider and approve the financial results for the period ended March 31, 202327-May-2023
Global Health LimitedFinancial ResultsTo consider and approve the financial results for the period ended Jun 30, 202310-Aug-2023
Global Health LimitedFinancial ResultsTo consider and approve the financial results for the period ended September 30, 202309-Nov-2023
Global Health LimitedFinancial ResultsTo consider and approve the financial results for the period ended December 31, 202308-Feb-2024
Global Health LimitedFinancial ResultsTo consider and approve the Standalone and Consolidated Audited Financial Results of the Company for the Fourth Quarter and Financial Year ended March 31, 2024.17-May-2024
Global Health LimitedFinancial ResultsTo consider and approve the financial results for the period ended Jun 30, 202408-Aug-2024
Global Health LimitedFinancial ResultsTo consider and approve the financial results for the period ended September 30, 202414-Nov-2024
Global Health LimitedFinancial ResultsTo consider and approve the financial results for the period ended December 31, 202404-Feb-2025

Share Transfers of Global Health Limited

CompanyPeriodReg.7Reg.40Reg7 Bcast DateReg40 Bcast Date
Global Health Limited31-MAR-2024 09-Apr-2024 17:40:0515-Apr-2024 17:10:08
Global Health Limited31-MAR-2023 10-Apr-2023 17:20:3115-Apr-2023 18:00:14

Voting Results of Global Health Limited

Date of Mtg.Mtg. TypeResolutionR. requiredTotal SHs% favour% against
27-DEC-2024Postal BallotApproval of winding up of the existing Global Health Limited - Employee Stock Option Plan 2021 of the CompanySpecial14984497.152.85
27-DEC-2024Postal BallotFinancial assistance by the Company to the employees for subscription of new shares of GHL and / purchase of existing shares of GHL from open market under GHL LTIP 2024 PlanSpecial14984482.6817.32
27-DEC-2024Postal BallotFinancial assistance by the Company to the Trust/ Trustees for subscription of new shares of GHL and / purchase of existing shares of GHL from open market under GHL LTIP 2024 PlanSpecial14984482.6817.32
27-DEC-2024Postal BallotAuthorization for set up of trust to subscribe to new shares of GHL and / purchase of existing shares of GHL from open market for the implementation of GHL LTIP 2024 PlanSpecial14984482.6817.32
27-DEC-2024Postal BallotGrant of options and / or shares of the Company to the employees of the Subsidiary/Associate Company(ies) under the GHL LTIP 2024 PlanSpecial14984482.6817.32
27-DEC-2024Postal BallotApproval of the Global Health Limited (GHL) Employees Long Term Share Based Incentive Plan -2024 consisting of Part A-GHL Employees Stock Option Scheme, 2024 and Part B-GHL Employees Stock Purchase Scheme, 2024 (ᅡ﾿ᅡ﾿ᅡ﾿collectively referred as GHL LTIP 2024 Planᅡ﾿ᅡ﾿ᅡ﾿) and its implementation through Trust (as may be required)Special14984482.6817.32
19-SEP-2024AGMTo consider and adopt the Standalone Financial Statements of the Company for the financial year ended March 31, 2024, the Consolidated Financial Statements for the financial year ended March 31, 2024 and the Reports of the Board of Directors and Auditors thereon.Ordinary1494521000
19-SEP-2024AGMTo approve the limit under Section 180 (1)(a) of the Companies Act,n2013 for creation of charge/pledge.Special14945291.488.52
19-SEP-2024AGMTo approve remuneration of M/s. Ramanath Iyer & Co., Cost Auditorsnof the Company for Financial Year 2024-25nOrdinary1494521000
19-SEP-2024AGMTo appoint a Director in place of Mr. Sunil Sachdeva (DIN-00012115) who retires by rotation and being eligible, offers himself for re-election.Ordinary14945299.040.96
03-AUG-2024Court Convened MeetingTo approve the Scheme of Amalgamation between Medanta Holdings Private Limited and Global Health Limited and their respective shareholders and creditors.Special13574498.611.39
26-JUN-2024Postal BallotPayment of Commission to Independent DirectorsOrdinary17215288.5811.42
20-SEP-2023AGMTo consider and adopt the Standalone Financial Statements of the Company for the financial year ended March 31, 2023, the Consolidated Financial Statements for the said financial year and the Reports of the Board of Directors and Auditors thereon.Ordinary1170621000
20-SEP-2023AGMTo ratify remuneration of M/s. Ramanath Iyer & Co., Cost Auditors of the Company for FY 2023-24Ordinary1170621000
20-SEP-2023AGMTo appoint a director in place of Mr. Ratnasami Venkatesh (DIN-03433678) who retires by rotation and being eligible, offers himself for re-election.Ordinary11706299.160.84
28-JAN-2023Postal BallotAppointment of Mr. Pankaj Prakash Sahni as a Director and Whole time DirectorOrdinary12772395.554.45
28-JAN-2023Postal BallotRatification of Global Health Limited Employee Stock Option Plan 2016Special12772396.083.92
28-JAN-2023Postal BallotRatification of Global Health Limited Employee Stock Option Plan 2021Special12772387.6712.33
28-JAN-2023Postal BallotRatification of Global Health Limited Employee Stock Option Plan 2021 to the eligible employees and directors of the Subsidiary Company (ies) and/or Holding Company, if any, of the CompanySpecial12772387.6712.33
28-JAN-2023Postal BallotAmendment in Articles of Association of the CompanySpecial12772387.4912.51

FAQs on Global Health Limited

Disclaimer: The information provided here is for informational purposes only and should not be considered financial advice. Please do your own research and consult with a financial professional before making any investment decisions.